<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01973348</url>
  </required_header>
  <id_info>
    <org_study_id>1307011930</org_study_id>
    <nct_id>NCT01973348</nct_id>
  </id_info>
  <brief_title>Comparison of AmblyzTM Glasses and Patching for Amblyopia</brief_title>
  <official_title>Comparison of AmblyzTM Glasses and Patching for Amblyopia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Electronic eyeglasses, Amblyz™glasses, are a new medical device designed to treat amblyopia,
      which intermittently become opaque and provide effective occlusion for 50% of the time they
      are worn. A non-randomized study reported that Amblyz glasses yield an improvement in the
      amblyopic eye and offer an alternative effective treatment. We are unaware of any randomized
      clinical trial reports of response to AmblyzTM glasses treatment of amblyopia.

      Our hypothesis: Amblyz™glasses can improve visual acuity of the amblyopic eye as effective as
      traditional patching treatment.

      The primary objective is to determine if AmblyzTM equally treats moderate amblyopia as the
      standard 2-hour patching treatment and AmblyzTM equally treats severe amblyopia as the
      standard 6-hour patching treatment.

      This study is designed to evaluate the effectiveness of a novel amblyopia treatment, AmblyzTM
      glasses, in treating amblyopia.

      Moderate amblyopia: Children ages 3 to &lt;8 years with visual acuity of 20/40 to 20/80 in the
      amblyopic eye will be enrolled and randomized into two groups: 4-hour AmblyzTM glasses
      treatment group and standard 2-hour patching control group.

      Severe amblyopia: Children ages 3 to &lt;8 years with visual acuity of 20/100 to 20/400 in the
      amblyopic eye will be enrolled and randomized into two groups: 12-hour AmblyzTM glasses
      treatment group and standard 6-hour patching control group.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    funding and personnel are lack.
  </why_stopped>
  <start_date>November 2013</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Acuity Change During 12 Weeks</measure>
    <time_frame>12 weeks</time_frame>
    <description>Visual acuity change during 12 weeks: the difference of visual acuity at baseline and 12 weeks.</description>
  </primary_outcome>
  <other_outcome>
    <measure>Reverse Amblyopia</measure>
    <time_frame>3 Months</time_frame>
    <description>it is defined that the strong eye of the patient decreases two logMAR lines over 3 months.</description>
  </other_outcome>
  <other_outcome>
    <measure>Significant Ocular Deviation Increase From the Baseline</measure>
    <time_frame>3 Months</time_frame>
    <description>The significant ocular deviation is defined as equal or over 10 degrees of deviation more than that of the baseline.</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Amblyopia</condition>
  <arm_group>
    <arm_group_label>4-hour AmblyZ glasses</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4-hour AmblyZ glasses for moderate amblyopia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2-hour eye patching</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2-hour eye patching for moderate amblyopia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>12-hour AmblyZ glasses</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>12-hour AmblyZ glasses for severe amblyopia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6-hour eye patching</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>6-hour eye patching for severe amblyopia</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>4-hour AmblyZ glasses</intervention_name>
    <description>4-hour AmblyZ glasses for moderate amblyopia</description>
    <arm_group_label>4-hour AmblyZ glasses</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>12-hour AmblyZ glasses</intervention_name>
    <description>12-hour AmblyZ glasses for severe amblyopia</description>
    <arm_group_label>12-hour AmblyZ glasses</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>2-hour patching</intervention_name>
    <description>2-hour patching for moderate amblyopia</description>
    <arm_group_label>2-hour eye patching</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>6-hour patching</intervention_name>
    <description>6-hour patching for severe amblyopia</description>
    <arm_group_label>6-hour eye patching</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Both genders and all races are eligible to this study.

          -  Age 3 to 8 years

          -  Amblyopia associated with strabismus, anisometropia, or both

          -  Visual acuity in the amblyopic eye between 20/40 and 20/80 inclusive

          -  Visual acuity in the sound eye 20/40 or better and inter-eye acuity difference &gt;3
             logarithm of the minimum angle of resolution (logMAR) lines

          -  Wearing of optimal spectacle correction for a minimum of 4 weeks at the time of
             enrollment.

        Exclusion Criteria:

        • No amblyopia treatment before enrollment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>8 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Riley Hospital for Children</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 25, 2013</study_first_submitted>
  <study_first_submitted_qc>October 25, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 31, 2013</study_first_posted>
  <results_first_submitted>April 25, 2017</results_first_submitted>
  <results_first_submitted_qc>July 20, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">July 24, 2017</results_first_posted>
  <last_update_submitted>July 25, 2017</last_update_submitted>
  <last_update_submitted_qc>July 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>amblyopia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amblyopia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methamphetamine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>49 patients were consented; 45 entered the trial, with 27 assigned to the IO therapy group and 18 to the patching group.</recruitment_details>
      <pre_assignment_details>49 patients were consented; 4 patients were not qualified.
45 entered the trial, with 27 assigned to the IO therapy group and 18 to the patching group</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>4-hour AmblyZ Glasses</title>
          <description>4-hour AmblyZ glasses for moderate amblyopia
4-hour AmblyZ glasses: 4-hour AmblyZ glasses for moderate amblyopia</description>
        </group>
        <group group_id="P2">
          <title>2-hour Eye Patching</title>
          <description>2-hour eye patching for moderate amblyopia
2-hour patching: 2-hour patching for moderate amblyopia</description>
        </group>
        <group group_id="P3">
          <title>12-hour AmblyZ Glasses</title>
          <description>12-hour AmblyZ glasses for severe amblyopia
12-hour AmblyZ glasses: 12-hour AmblyZ glasses for severe amblyopia</description>
        </group>
        <group group_id="P4">
          <title>6-hour Eye Patching</title>
          <description>6-hour eye patching for severe amblyopia
6-hour patching: 6-hour patching for severe amblyopia</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="18"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>4-hour AmblyZ Glasses</title>
          <description>4-hour AmblyZ glasses for moderate amblyopia
4-hour AmblyZ glasses: 4-hour AmblyZ glasses for moderate amblyopia</description>
        </group>
        <group group_id="B2">
          <title>2-hour Eye Patching</title>
          <description>2-hour eye patching for moderate amblyopia
2-hour patching: 2-hour patching for moderate amblyopia</description>
        </group>
        <group group_id="B3">
          <title>12-hour AmblyZ Glasses</title>
          <description>12-hour AmblyZ glasses for severe amblyopia
12-hour AmblyZ glasses: 12-hour AmblyZ glasses for severe amblyopia</description>
        </group>
        <group group_id="B4">
          <title>6-hour Eye Patching</title>
          <description>6-hour eye patching for severe amblyopia
6-hour patching: 6-hour patching for severe amblyopia</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="19"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="0"/>
            <count group_id="B4" value="0"/>
            <count group_id="B5" value="34"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B5" value="34"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>year old</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.7" spread="1.5"/>
                    <measurement group_id="B2" value="5.9" spread="0.9"/>
                    <measurement group_id="B5" value="5.8" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B5" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B5" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B5" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Visual Acuity Change During 12 Weeks</title>
        <description>Visual acuity change during 12 weeks: the difference of visual acuity at baseline and 12 weeks.</description>
        <time_frame>12 weeks</time_frame>
        <population>Visual acuity change over 12 weeks</population>
        <group_list>
          <group group_id="O1">
            <title>4-hour AmblyZ Glasses</title>
            <description>4-hour AmblyZ glasses for moderate amblyopia
4-hour AmblyZ glasses: 4-hour AmblyZ glasses for moderate amblyopia</description>
          </group>
          <group group_id="O2">
            <title>2-hour Eye Patching</title>
            <description>2-hour eye patching for moderate amblyopia
2-hour patching: 2-hour patching for moderate amblyopia</description>
          </group>
          <group group_id="O3">
            <title>12-hour AmblyZ Glasses</title>
            <description>12-hour AmblyZ glasses for severe amblyopia
12-hour AmblyZ glasses: 12-hour AmblyZ glasses for severe amblyopia</description>
          </group>
          <group group_id="O4">
            <title>6-hour Eye Patching</title>
            <description>6-hour eye patching for severe amblyopia
6-hour patching: 6-hour patching for severe amblyopia</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Acuity Change During 12 Weeks</title>
          <description>Visual acuity change during 12 weeks: the difference of visual acuity at baseline and 12 weeks.</description>
          <population>Visual acuity change over 12 weeks</population>
          <units>logMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".15" spread=".12"/>
                    <measurement group_id="O2" value=".15" spread=".11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A sample size of 12 subjects per group has been shown to be effective for estimating within-group means and variances when little prior data is available.(Julius, 2005) Based on collected data from 34 subjects and effective size difference of 0.1, we reestimate this study as a noninferiority trial with continuous outcome and power calculated as approximately 80%.</non_inferiority_desc>
            <p_value>0.88</p_value>
            <method>t-test, 1 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Reverse Amblyopia</title>
        <description>it is defined that the strong eye of the patient decreases two logMAR lines over 3 months.</description>
        <time_frame>3 Months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>4-hour AmblyZ Glasses</title>
            <description>4-hour AmblyZ glasses for moderate amblyopia
4-hour AmblyZ glasses: 4-hour AmblyZ glasses for moderate amblyopia</description>
          </group>
          <group group_id="O2">
            <title>2-hour Eye Patching</title>
            <description>2-hour eye patching for moderate amblyopia
2-hour patching: 2-hour patching for moderate amblyopia</description>
          </group>
          <group group_id="O3">
            <title>12-hour AmblyZ Glasses</title>
            <description>12-hour AmblyZ glasses for severe amblyopia
12-hour AmblyZ glasses: 12-hour AmblyZ glasses for severe amblyopia</description>
          </group>
          <group group_id="O4">
            <title>6-hour Eye Patching</title>
            <description>6-hour eye patching for severe amblyopia
6-hour patching: 6-hour patching for severe amblyopia</description>
          </group>
        </group_list>
        <measure>
          <title>Reverse Amblyopia</title>
          <description>it is defined that the strong eye of the patient decreases two logMAR lines over 3 months.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Significant Ocular Deviation Increase From the Baseline</title>
        <description>The significant ocular deviation is defined as equal or over 10 degrees of deviation more than that of the baseline.</description>
        <time_frame>3 Months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>4-hour AmblyZ Glasses</title>
            <description>4-hour AmblyZ glasses for moderate amblyopia
4-hour AmblyZ glasses: 4-hour AmblyZ glasses for moderate amblyopia</description>
          </group>
          <group group_id="O2">
            <title>2-hour Eye Patching</title>
            <description>2-hour eye patching for moderate amblyopia
2-hour patching: 2-hour patching for moderate amblyopia</description>
          </group>
          <group group_id="O3">
            <title>12-hour AmblyZ Glasses</title>
            <description>12-hour AmblyZ glasses for severe amblyopia
12-hour AmblyZ glasses: 12-hour AmblyZ glasses for severe amblyopia</description>
          </group>
          <group group_id="O4">
            <title>6-hour Eye Patching</title>
            <description>6-hour eye patching for severe amblyopia
6-hour patching: 6-hour patching for severe amblyopia</description>
          </group>
        </group_list>
        <measure>
          <title>Significant Ocular Deviation Increase From the Baseline</title>
          <description>The significant ocular deviation is defined as equal or over 10 degrees of deviation more than that of the baseline.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 months</time_frame>
      <desc>In addition to monitoring all Serious and non-serious adverse events, participants were specifically monitored/assessed for the following two major Other adverse events:
reverse amblyopia (the fellow good eye becomes two logMAR line worse than the amblyopic eye)
Significant deviation increase than baseline.</desc>
      <group_list>
        <group group_id="E1">
          <title>4-hour AmblyZ Glasses</title>
          <description>4-hour AmblyZ glasses for moderate amblyopia
4-hour AmblyZ glasses: 4-hour AmblyZ glasses for moderate amblyopia</description>
        </group>
        <group group_id="E2">
          <title>2-hour Eye Patching</title>
          <description>2-hour eye patching for moderate amblyopia
2-hour patching: 2-hour patching for moderate amblyopia</description>
        </group>
        <group group_id="E3">
          <title>12-hour AmblyZ Glasses</title>
          <description>12-hour AmblyZ glasses for severe amblyopia
12-hour AmblyZ glasses: 12-hour AmblyZ glasses for severe amblyopia</description>
        </group>
        <group group_id="E4">
          <title>6-hour Eye Patching</title>
          <description>6-hour eye patching for severe amblyopia
6-hour patching: 6-hour patching for severe amblyopia</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Sample size is limited; some patients did not come for followup visit.
Compliance with treatment is only estimated with calendar log and many patients did not bring back report.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Daniel Neely, PI</name_or_title>
      <organization>Indiana University</organization>
      <phone>3172741214</phone>
      <email>deneely@iupui.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

